精准医学时代肝细胞癌的治疗:从治疗阶段迁移到治疗层级
本综述批判性分析了肝细胞癌(HCC)管理的不同概念方法,重点比较了以巴塞罗那临床肝癌(BCLC)方案为代表的「阶段层级」策略与「治疗层级」策略。文章阐述了欧美指南引入的「治疗阶段迁移」和「治疗阶段替代」等灵活性元素,并指出亚太治疗算法及意大利多学会指南历史上支持治疗层级概念,强调了阶段导向与层级策略之间的显著差异。
要点
- HCC治疗分配复杂,因多数患者伴有肝硬化和合并症。
- 「阶段层级」策略将疾病阶段与特定治疗链接,是西方主要管理策略。
- 欧美指南引入治疗阶段迁移和替代以增加灵活性。
核心结论
- 肝细胞癌的治疗分配极其复杂,阶段层级策略是西方主要管理策略,但治疗层级策略提供了另一种基于疗效的决策框架。
研究设计与样本
- 本文为综述,批判性分析了肝细胞癌管理的不同概念方法,未报告系统检索范围。
主要发现
- 最新欧美指南引入了治疗阶段迁移和治疗阶段替代等灵活性元素,这些并非原始BCLC方案固有。
- 治疗阶段迁移允许在当前阶段相关治疗不可行时转向后续阶段的治疗。
- 治疗阶段替代为每个BCLC定义阶段提出进一步治疗选项。
- 治疗层级概念历史上被亚太治疗算法和意大利多学会指南认可。
临床怎么用
- 临床管理HCC时需考虑阶段层级策略的灵活性元素,如治疗阶段迁移和替代。
- 可参考治疗层级策略,根据治疗疗效而非仅肿瘤阶段做决策。
局限性
- 本文为综述,未报告原始研究数据或样本量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Treatment allocation is extremely complex in patients with hepatocellular carcinoma (HCC) because this neoplasm arises, in most cases, in patients with cirrhosis and additional comorbidities. The "stage hierarchy" approach, which involves linking each stage (or substage) of the disease to a specific treatment, has become the main proposed treatment strategy for the clinical management of HCC, particularly in the West. The Barcelona Clinic Liver Cancer (BCLC) scheme serves as the main example of the application of this strategy. In an attempt to increase the plasticity of the "stage hierarchy" approach as well as its adaptability to the requirements of real-world clinical practice, the latest versions of European and American guidelines have introduced certain relevant elements of flexibility, which were not intrinsic to the original BCLC scheme. These elements are as follows: the "treatment stage migration" strategy, which allows moving to another treatment (generally the one that is associated with the subsequent stage) if the approach linked with the current stage proves to be unfeasible, and the "treatment stage alternative" approach, which proposes further therapeutic options for each BCLC-defined stage. In regard to most of the solid cancers, another potential strategy is to consider the treatment decision to be hierarchically dictated by the efficacy of each therapy with complete or partial independence from the tumor stage. This concept of "therapeutic hierarchy" has been historically endorsed by the Asia-Pacific treatment algorithm as well as by the recent Italian multisociety guidelines. The present review provides a critical analysis of the different conceptual approaches to HCC management, highlighting their advantages and disadvantages and focusing on the remarkable differences between the stage-guided and the hierarchical strategies.
引用
- Vitale A, Trevisani F, Farinati F, et al. Treatment of Hepatocellular Carcinoma in the Precision Medicine Era: From Treatment Stage Migration to Therapeutic Hierarchy. Hepatology. 2020. PMID: 32064645. doi:10.1002/hep.31187
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。